Drug firm Lupin today said its consolidated net profit rose by 4.95% to Rs 235.1 crore for the third quarter ended December 31, 2011, over the same period last fiscal.
The company had posted a net profit of Rs 224 crore for the corresponding period of previous fiscal.
Net sales of the company grew by 21.9% to Rs 1,791.7 crore for the third quarter, compared to Rs 1,469.4 crore in the same period previous fiscal.
Shares of Lupin were trading at Rs 448.45 on the BSE in the late afternoon trade, up 2.51% from its previous close.